Geoffrey Siwo is currently a Research Scientist at IBM Research-Africa in Johannesburg, South Africa where he is initiating new projects in data driven healthcare. His main interest is in developing scalable technologies for large scale medical discovery, especially in Africa. Previously, he co-founded several award winning teams leveraging computing and biology to seek solutions to tough biological problems including Helix Nanotechnologies- a DNA nanotechnology company, Fit2Cure - a computer game for finding new medicines, DNAge - a computational pipeline for predicting human age from DNA awarded top prize out of 417 teams in an open innovation challenge by Innocentive and Nature Publishing Group, and FIrST - the top team in an open innovation challenge to predict activity of genes from DNA.
He is the recipient of several awards including a TED Fellow, Young African Committed to Excellence (YACE), Young Investigator (Sage Bionetworks), IBM PhD scholarship award recipient and Eck Institute of Global Health Fellow. His work has been featured in several media including USA Today and Fast Company.
He received his PhD in Biological Sciences at the University of Notre Dame (2014) working on computational models for understanding malaria drug resistance. He performed post-doctoral research at the University of Pennsylvania (Perelman School of Medicine) and Dartmouth College (Geisel School of Medicine).